BCI Pharma Services, a specialist in the pharmaceutical industries and a subsidiary of the Partners Group, announced the signing of an agreement under which it will acquire Mubadala Investment and Coleberg & Company ( Kohlberg) holds a majority stake in the company.
According to Al Bayan newspaper, the Partners Group has agreed to sell its majority stakes in BCI Pharma on behalf of its clients, along with its two consortium partners, Thomas H. Lee And Fraser Healthcare Partners.
The Partners Group will maintain a minority stake in the company. Mubadala and Kohlberg plan to collaborate with the BCI management team to help continue its growth path.
(Amazon fun knowledge)
